0001225208-24-005334.txt : 20240429
0001225208-24-005334.hdr.sgml : 20240429
20240429170613
ACCESSION NUMBER: 0001225208-24-005334
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240425
FILED AS OF DATE: 20240429
DATE AS OF CHANGE: 20240429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: West Nadja
CENTRAL INDEX KEY: 0001787802
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03215
FILM NUMBER: 24892473
MAIL ADDRESS:
STREET 1: 1915 REXFORD ROAD
CITY: CHARLOTTE
STATE: NC
ZIP: 28211
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON
CENTRAL INDEX KEY: 0000200406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 221024240
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1229
BUSINESS ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
BUSINESS PHONE: 732-524-2455
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
4
1
doc4.xml
X0508
4
2024-04-25
0000200406
JOHNSON & JOHNSON
JNJ
0001787802
West Nadja
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933
1
0
Deferred Share Units
2024-04-25
4
A
0
1385.6970
0.0000
A
Common Stock
1385.6970
5093.6820
D
Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).
Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
/s/ Raavi K. Deol, as attorney-in-fact for Nadja Y. West
2024-04-29